In Vivo Selection of Phage Sequences and Characterization of Peptide-specific Binding to Breast Cancer Cells

References

1. ↵
   1. Hortobagyi GN.

   Opportunities and challenges in the development of targeted therapies. Semin Oncol 2004; 31: 21-27.

   OpenUrlPubMed
2. ↵
   1. Li XB,
   2. Schluesener HJ,
   3. Xu SQ.

   Molecular addresses of tumors: selection by in vivo phage display. Arch Immunol Ther Exp (Warsz) 2006; 54: 177-813.

   OpenUrlPubMed
3. ↵
   1. Poul MA,
   2. Becerril B,
   3. Nielsen UB, et al.

   Selection of tumor-specific internalizing human antibodies from phage libraries. J Mol Biol 2000; 301:1149–1161.

   OpenUrlCrossRefPubMedWeb of Science
4. ↵
   1. Pasqualin R,
   2. Ruoslahti E.

   Organ targeting in vivo using phage display peptide libraries. Nature 1996; 380: 364-366.

   OpenUrlCrossRefPubMedWeb of Science
5. ↵
   1. Viti F,
   2. Tarli L,
   3. Giovannoni L, et al.

   Increased binding affinity and valence of recombinant antibody fragments lead to improved targeting of tumoral angiogenesis. Cancer Res 1999; 59: 347-352.

   OpenUrlAbstract/FREE Full Text
6. 1. Arap W,
   2. Pasqualini R,
   3. Ruoslahti E.

   Cancer treatment by targeting drug delivery to tumor vasculature in a mouse model. Science 1998; 279: 377-380.

   OpenUrlAbstract/FREE Full Text
7. ↵
   1. Karasseva NG,
   2. Glinsky VV,
   3. Chen NX, et al.

   Identification and characterization of peptides that bind human ErbB-2 selected from a bacteriophage display library. Protein Chem 2002; 21: 287-296.

   OpenUrl
8. ↵
   1. Newton JR,
   2. Kelly KA,
   3. Mahmood U, et al.

   In vivo selection of phage for the optical imaging of PC-3 human prostate carcinoma in mice. Neoplasia 2006; 8: 772–780.

   OpenUrlCrossRefPubMedWeb of Science
9. ↵
   1. Zhu Y,
   2. Zhang SW,
   3. Jia XH, et al.

   Pathologic study in characteristic of spontaneous breast cancer in TA II mice. J Tianjin Med Univ 2007; 13: 149-150(Chinese).

   OpenUrl
10. ↵
    1. Sun H,
    2. Hao XH,
    3. Zhan ZL, et al.

    Establishment of lung metastasis models of breast cancer in TA2 inbred mice and their biological characteristics. Chin J Clini Oncol 2003; 30: 886-890 (Chinese)

    OpenUrl
11. ↵
    1. Yu WB and
    2. Gu JC.

    The construction of breast cancer animal model. Inter J Surgery 2005; 32: 63-66 (Chinese).

    OpenUrl
12. ↵
    1. Wang Y,
    2. Wu KC,
    3. Nie YZ et al.

    In vivo screening and characterization of peptides specific binding to vasculature of gastric cancer. Chin J Cell Mol Immunol 2003; 19: 469-472 (Chinese).

    OpenUrl
13. ↵
    1. Jiang YQ,
    2. Wang HR,
    3. Li HP, et al.

    Targeting of hepatoma cell and suppression of tumor growth by a novel 12mer peptide fused to superantigen TSST-1. Mol Med 2006; 12: 81-87.

    OpenUrlPubMed
14. ↵
    1. Valadon P,
    2. Garnett JD,
    3. Testa JE. et al.

    , Screening phage display libraries for organ-specific vascular immunotargeting in vivo. Proc Natl Acad Sci 2006; 103: 407-412.

    OpenUrlAbstract/FREE Full Text
15. ↵
    1. Askoxylakis V,
    2. Zitzmann S,
    3. Mier W, et al.

    Preclinical evaluation of the breast cancer cell-binding peptide, p160. Clin Cancer Res 2005; 11: 6705-6712.

    OpenUrlAbstract/FREE Full Text